Bookstore Search

The 2020 PDA Research Particulate Matter in Flexible Containers Survey was undertaken to address the industry-wide concern raised by multiple recalls for particulate matter in flexible container and other container products dating back to 2012.This survey was conducted to establish a benchmark of current …

Serialization in the pharmaceutical supply chain is a growing effort to improve shortcomings within the current track and trace processes. The survey will help PDA members, industry, and regulators understand the current state of demand and issues surrounding track and trace and attain additional insight …

This survey is designed to align and expand PDA's insight on current practices for companies that manufacture sterile lyophilized drug products and conduct lyophilizer loading. It also provides insight into how today's lyophilizer loading area operations can be improved to reduce contamination from …

The 2017 PDA Glass Quality Survey is designed to assist in the identification of glass container quality concerns and development of solutions to overcoming them. Survey topics include glass sampling and inspection practices, product complaints and recalls due to glass defects, and quality …

Aging facilities contribute to a variety of challenges in pharmaceutical manufacturing, including drug shortages and product recalls. In response to calls for support in this area from industry and regulators, PDA established an Aging Facility Task Force to focus on the identification and modernization …

Due to the lack of detailed guidance and best practices for inspection and particle control in difficult to inspect parenteral (DIP) products, PDA has established a technical report team to address particulate matter in difficult to inspect parenterals. As a first step in developing a better understanding …

Particulate matter in oral dosage forms has been the subject of customer complaints, recalls and regulatory actions. However, there is currently no clear industry standard or guidance on mitigation, acceptance criteria, clinical relevance, inspection, sampling, testing or acceptable complaint levels …

This publication presents the results of the PDA Quality Culture Metrics Surveys conducted in September and October 2014. Because similar questions were asked, two sets of results are shown side by side: those from the survey open to all PDA members and those from the survey sent to Heads of Quality …

Appropriate standards, glass supplier reliability, and pharmaceutical manufacturer handling and distribution best practices are all necessary elements of maintaining container integrity and product sterility assurance throughout the product lifecycle of sterile injectable pharmaceutical and biopharmaceutical …

The issue of Tribromoanisole (TBA) or Trichloroanisole (TCA) tainting is relatively new to the consumer healthcare and pharmaceutical industries. Since early 2010, there have been multiple drug and consumer healthcare product recalls for musty/moldy odors and lack of experience with taints in our …